pasireotide (as pasireotide diaspartate) 0.3 MG per 1 ML Injection

RxCUI: 1364109
RxNorm name: pasireotide (as pasireotide diaspartate) 0.3 MG per 1 ML Injection
Display name: pasireotide (as pasireotide diaspartate) 0.3 MG per 1 ML Injection
Full name: pasireotide (as pasireotide diaspartate) 0.3 MG per 1 ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Signifor	PASIREOTIDE	Recordati Rare Diseases, Inc.	a09a25fc-a5a3-0c82-e053-2995a90a5d74	2026-02-17	Warnings, Adverse reactions	Exact identifier rxcui: 1364109

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
a09a25fc-a5a3-0c82-e053-2995a90a5d74	pasireotide (as pasireotide diaspartate) 0.3 MG per 1 ML Injection	SY	20	These highlights do not include all the information needed to use SIGNIFOR safely and effectively. See full prescribing information for SIGNIFOR. SIGNIFOR ® (pasireotide) injection, for subcutaneous use Initial U.S. Approval: 2012	20260217
a09a25fc-a5a3-0c82-e053-2995a90a5d74	pasireotide 0.3 MG per 1 ML Injection	SY	20	These highlights do not include all the information needed to use SIGNIFOR safely and effectively. See full prescribing information for SIGNIFOR. SIGNIFOR ® (pasireotide) injection, for subcutaneous use Initial U.S. Approval: 2012	20260217
a09a25fc-a5a3-0c82-e053-2995a90a5d74	pasireotide 0.3 MG in 1 ML Injection	PSN	20	These highlights do not include all the information needed to use SIGNIFOR safely and effectively. See full prescribing information for SIGNIFOR. SIGNIFOR ® (pasireotide) injection, for subcutaneous use Initial U.S. Approval: 2012	20260217
a09a25fc-a5a3-0c82-e053-2995a90a5d74	1 ML pasireotide 0.3 MG/ML Injection	SCD	20	These highlights do not include all the information needed to use SIGNIFOR safely and effectively. See full prescribing information for SIGNIFOR. SIGNIFOR ® (pasireotide) injection, for subcutaneous use Initial U.S. Approval: 2012	20260217